|
Immuno-Oncology Summit 2025
Conference in-person 11th to 13th August 2025 Philadelphia, Pennsylvania, United States of America Website: https://cii.dryfta.com/eid/357/pid/47 Contact person: CHI Commercializing breakthrough immune-oncology therapeutics is becoming increasingly challenging due to funding limitations, high cost and attrition rates in the clinic, regulatory uncertainties, persistent therapeutic safety and efficacy concerns, and Organized by: CHI Check the event website for more details. View all events from this organizer.
|
